Eagle Global Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $281K | Sell |
|
|||||
|
2021
Q4 | $319K | Sell |
|
|||||
|
2021
Q3 | $6.01M | Buy |
|
|||||
|
2021
Q2 | $4.86M | Buy |
|
|||||
|
2021
Q1 | $2.57M | Buy |
|
|||||
|
2020
Q4 | $3.06M | Buy |
|
|||||
|
2020
Q3 | $2.14M | Buy |
|
|||||
|
2020
Q2 | $3.04M | Buy |
|
|||||
|
2020
Q1 | $1.16M | Buy |
|
|||||
|
2019
Q4 | $1.53M | Hold |
|
|||||
|
2019
Q3 | $602K | Hold |
|
|||||
|
2019
Q2 | $708K | Buy |
|
|||||
|
2019
Q1 | $547K | Buy |
|
|||||
|
2018
Q4 | $337K | Buy |
|